SOUTH SAN FRANCISCO, Calif., Jan. 30, 2014 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, announced that Peter Langecker, M.D., PhD., President and Chief Executive Officer, will provide a corporate overview at the 16th annual BIO CEO & Investor conference on February 11, 2014 at 11:00 am ET at the Waldorf Astoria Hotel in New York City.
Help employers find you! Check out all the jobs and post your resume.
